Biosynthetic pathways are the molecular assembly lines that cells use to build complex molecules from simple precursors. In synthetic biology, these pathways are transplanted, modified, or entirely redesigned to produce valuable compounds in microbial hosts. One of the most celebrated examples is the engineering of artemisinic acid production in yeast by Jay Keasling's lab and Amyris, which transferred a multi-gene plant pathway into Saccharomyces cerevisiae to produce the antimalarial drug precursor at industrial scale.
The engineering of biosynthetic pathways requires balancing enzyme expression levels, managing intermediate toxicity, and optimizing cofactor availability. Companies like Ginkgo Bioworks use high-throughput combinatorial approaches to explore vast pathway design spaces, testing thousands of enzyme variants and expression configurations in parallel. Arzeda applies computational enzyme design to optimize pathway enzymes, while Antheia has reconstructed complex plant natural product pathways in yeast to produce pharmaceutical compounds like tropane alkaloids that are difficult to source from natural plants.
Discovery of new biosynthetic pathways from nature continues to expand the chemical diversity accessible through engineering. Genome mining tools powered by bioinformatics can identify cryptic biosynthetic gene clusters in microbial genomes, revealing pathways to novel natural products. Databases like MIBiG catalog characterized biosynthetic gene clusters, providing blueprints that synthetic biologists can adapt and optimize. The combination of pathway discovery, computational design, and high-throughput engineering is steadily expanding the catalog of molecules that can be produced sustainably through biology.